Free Trial
NASDAQ:PULM

Pulmatrix (PULM) Stock Price, News & Analysis

Pulmatrix logo
$6.61 -0.29 (-4.20%)
Closing price 04:00 PM Eastern
Extended Trading
$6.64 +0.02 (+0.38%)
As of 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pulmatrix Stock (NASDAQ:PULM)

Key Stats

Today's Range
$6.53
$6.92
50-Day Range
$6.08
$9.09
52-Week Range
$1.78
$10.40
Volume
13,643 shs
Average Volume
137,681 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pulmatrix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

PULM MarketRank™: 

Pulmatrix scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pulmatrix.

  • Percentage of Shares Shorted

    0.84% of the float of Pulmatrix has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulmatrix has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pulmatrix has recently increased by 40.18%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pulmatrix does not currently pay a dividend.

  • Dividend Growth

    Pulmatrix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.84% of the float of Pulmatrix has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulmatrix has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pulmatrix has recently increased by 40.18%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Pulmatrix has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Pulmatrix this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Pulmatrix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.62% of the stock of Pulmatrix is held by insiders.

  • Percentage Held by Institutions

    Only 11.84% of the stock of Pulmatrix is held by institutions.

  • Read more about Pulmatrix's insider trading history.
Receive PULM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulmatrix and its competitors with MarketBeat's FREE daily newsletter.

PULM Stock News Headlines

Pulmatrix Inc.
Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
See More Headlines

PULM Stock Analysis - Frequently Asked Questions

Pulmatrix's stock was trading at $6.98 at the beginning of the year. Since then, PULM stock has decreased by 5.3% and is now trading at $6.61.
View the best growth stocks for 2025 here
.

Pulmatrix, Inc. (NASDAQ:PULM) posted its quarterly earnings results on Thursday, May, 15th. The biotechnology company reported ($0.50) earnings per share (EPS) for the quarter. Pulmatrix had a negative net margin of 122.46% and a negative trailing twelve-month return on equity of 94.97%.

Pulmatrix's stock reverse split on the morning of Tuesday, March 1st 2022.The 1-20 reverse split was announced on Tuesday, March 1st 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 1st 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of PULM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulmatrix investors own include NVIDIA (NVDA), CymaBay Therapeutics (CBAY), GE Aerospace (GE), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO) and Adobe (ADBE).

Company Calendar

Last Earnings
5/15/2025
Today
7/01/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PULM
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.94 million
Net Margins
-122.46%
Pretax Margin
-498.39%

Debt

Sales & Book Value

Annual Sales
$7.81 million
Price / Cash Flow
N/A
Book Value
$2.45 per share
Price / Book
2.70

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.37

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:PULM) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners